PARSLOW JAMES F has filed 3 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 100000 shares of Xenetic Biosciences, Inc. ($XBIO) on April 21, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 21, 2026 | Xenetic Biosciences, Inc. | $XBIO | PARSLOW JAMES F | Interim CEO and CFO | A | Common Stock | 100000 | $0.00 | 100,000.0000 | 2,291,056 | 9999.99% | 4.36% |
| June 18, 2024 | Xenetic Biosciences, Inc. | $XBIO | PARSLOW JAMES F | Interim CEO and CFO | A | Stock Options | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 11, 2023 | Xenetic Biosciences, Inc. | $XBIO | PARSLOW JAMES F | Chief Financial Officer | A | Stock Options | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |